Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Sanofi’s Dupixent improves symptoms for adolescent atopic dermatitis patients

September 17, 2018 Research and Development, Sales and Marketing Dupixent, EADV 2018, Sanofi, atopic dermatitis, pharma

Sanofi’s Dupixent (dupilumab) has made a strong showing as a monotherapy at Phase 3 in the treatment of moderate-to-severe atopic …
News
georg-terstappen

Ex-GSK R&D head joins OxStem as CSO

September 14, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, OxStem, University of Oxford

OxStem, a regenerative drug discovery unit spun out from the University of Oxford, has brought on board ex-GlaxoSmithKline R&D exec …
Appointment

UCB brings promising plaque psoriasis data to EADV 2018

September 14, 2018 Medical Communications, Research and Development EADV 2018, UCB, pharma, psoriasis

UCB has joined in on the wave of new psoriasis data emerging from the European Academy of Dermatology and Venereology …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

September 14, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myers Squibb, FDA, NICE, Novo Nordisk, Spinraza, brexit, bristol myers squibb, top 10

With the Pharmafocus team having avoided hurricane Florence and finally arriving back in the UK just last night, after stopping …
News
carina_web

Living with fibromyalgia

September 13, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing fibromyalgia, patient experience

Scottish comedian Carina MacLeod recounts her life with fibromyalgia and the benefits of comedy in dealing with a chronic condition, …
Feature
novartis_outside_1

Novartis doubles down on Cosentyx’s efficacy in psoriasis with extensive real-world data

September 13, 2018 Research and Development Cosentyx, Novartis, pharma, psoriasis

Novartis was yet another company to reveal new data on a psoriasis drug at the European Academy of Dermatology and …
News
celgene_1_02

Celgene’s Otezla produces “meaningful benefits” beyond traditional metrics in plaque psoriasis

September 13, 2018 Research and Development Celgene, otezla, pharma, psoriasis

Celgene made its voice heard amongst the chorus of new psoriasis data emerging from the European Academy of Dermatology and …
News
janssen_latest_logo_on_sign

Phase 3 data presents strong case for switching from Humira to Janssen’s Tremfya in plaque psoriasis

September 13, 2018 Research and Development Humira, Janssen, Tremfya, pharma, psoriasis

Janssen has unveiled new Phase 3 data derived from two separate trials on the efficacy and benefits of switching to …
News

Takeda set to move from Deerfield Illinois, 1000 jobs affected

September 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jobs, Shire, Takeda, deerfield, illinois

Japanese multinational Takeda is set to shut down its US headquarters in Deerfield, Illinois following the final stages of its …
News
john_nason

Teva names new President, TAPI and Biologics Operations

September 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Novartis, Teva, appointment

Israeli generic drug specialist Teva has announced its appointment of John Nason in a multi-faceted role as President of Teva …
Appointment
shutterstock_159488225

Merck KGaA and Pfizer’s combo impresses in first-line treatment of advanced kidney cancer

September 12, 2018 Research and Development, Sales and Marketing Cancer, Kidney cancer, Merck KGaA, Pfizer, pharma

Bavencio (avelumab), Merck KGaA and Pfizer’s human anti-programmed death ligand-1 (PD-L1) antibody, combined with the latter’s Inlyta (axitinib) has shown …
News

BMS’ investigational psoriasis drug hits primary endpoint in skin clearance at Phase 2

September 12, 2018 Research and Development BMS, BMS-986165, Bristol-Myers Squibb, pharma, psoriasis

Bristol-Myers Squibb has unveiled new Phase 2 data for its investigational oral, selective tyrosine kinase 2 (TYK2) inhibitor, known as …
News
injection

More effective flu vaccine could prevent hundreds of elderly deaths across UK this winter

September 12, 2018 Medical Communications, Research and Development NHS, Vaccine, flu, influenza, pharma

Public Health England has revealed that an enhanced, “adjuvanted” vaccine is to be made available for over-65s this winter, and …
News
14680814113_e81affc144_z_1

UK Health Secretary Matt Hancock rallies against ‘rip off’ pharma companies

September 11, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen, Matt Hancock, NICE, Vertex, pharma, pricing

British Health Secretary Matt Hancock has said that pharmaceutical companies are trying to “rip off taxpayers” and that big business …
News

Protesters in Manchester call on NICE to approve Biogen’s $750,000 drug Spinraza

September 11, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, Spinraza, approval, protest, sma

Protesters in Manchester have called on the National Institute of Health and Care Excellence (NICE), to overturn their rejection of …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026